Talwar Thakore & Associates (TT&A) advised IFU on their equity investment of USD 20 million in RedCliffe Lifetech Private Limited (RedCliffe Labs), a prominent provider of diagnostic services in India.
The investment was structured through an offshore holding company, RedCliffe Lifetech Inc.
The TT&A team included Partners Dushyant Bagga and Amrita Patnaik, Managing Associates Akshita Alok and Ambika Sahai, and Senior Associates Aditi Somani and Tanya Maithani.
RedCliffe Lifetech Private Limited (RedCliffe Labs), an omnichannel diagnostics service provider, has successfully raised $42 million in its Series C funding round. Leading the investment is IFU (Investeringsfonden for Udviklingslande), Denmark’s Investment Fund for Developing Countries, contributing $20 million. Existing investor LeapFrog Investments followed with $15 million, while the remaining capital came from current shareholders HealthQuad and Spark Growth Ventures.
The newly acquired funds will support RedCliffe’s expansion plans, particularly in deepening its presence in Tier-II and Tier-III cities throughout India. The company aims to open more labs and collection centers, as well as enhance its home collection network. Additionally, RedCliffe is pursuing a pan-India expansion strategy through strategic partnerships and further acquisitions, having already made moves in northwestern India.
Share your news, articles, deals, columns, or press releases with us! Click the link to submit and join our platform today.
